title: Curative resection of double primary lung cancer after 15-month bortezomib administration.
authors.forename: Hiroya
authors.initials: H
authors.lastname: Tamaki
authors.forename: Masaki
authors.initials: M
authors.lastname: Hashimoto
authors.forename: Yoshiro
authors.initials: Y
authors.lastname: Naito
authors.forename: Masaaki
authors.initials: M
authors.lastname: Lee-Kawabata
authors.forename: Tohru
authors.initials: T
authors.lastname: Masuyama
authors.forename: Hiroyasu
authors.initials: H
authors.lastname: Ogawa
authors.forename: Seiki
authors.initials: S
authors.lastname: Hasegawa
mesh_terms: D001897:Boronic Acids / Q000008:administration & dosage*; D000069286:Bortezomib; D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis / Q000628:therapy*; D003131:Combined Modality Therapy / Q000379:methods; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009378:Neoplasms, Multiple Primary / Q000175:diagnosis / Q000628:therapy*; D011013:Pneumonectomy / Q000379:methods*; D011719:Pyrazines / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib